{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:44:36Z","timestamp":1780393476959,"version":"3.54.1"},"reference-count":17,"publisher":"The Pediatric Pharmacy Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"abstract":"\n OBJECTIVE<\/jats:title>\n To evaluate adherence to an institutional continuous infusion propofol policy for sedation in mechanically ventilated patients, investigate the rate of propofol-related infusion syndrome (PRIS), and explore areas of improvement to enhance policy compliance and safety.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n This was a single center, retrospective chart review of patients admitted to a pediatric or cardiac intensive care unit within a large free-standing quaternary care pediatric hospital who received continuous propofol for non-procedural continuous sedation for at least 6 hours between 2014 and 2019. Propofol exposure (dose and duration), laboratory data, and hemodynamic outcomes of patients were evaluated.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n A total of 104 patients (108 admissions and 133 treatment courses) met inclusion criteria. Policy adherence to propofol dosing and duration limitations were 70% (93\/133 courses) and 68% (91\/133 courses), respectively. Adherence to all elements of laboratory and hemodynamic monitoring was 23%. Hypotension and bradycardia were common among patients during propofol treatment courses. Except for hypertriglyceridemia, no significant difference in specific laboratory values were detected between patients exposed to greater than 66 mcg\/kg\/min (4 mg\/kg\/hr), compared with those exposed to less than 66 mcg\/kg\/min of propofol. Patients receiving therapy for longer than 48 hours had the highest rates of laboratory values associated with PRIS. No patient in the study cohort met full criteria for PRIS.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS<\/jats:title>\n Adherence to elements of an institutional propofol policy was variable. Improvements in policy adherence may be enhanced by updating policy features, leveraging the electronic medical record order-set, and gaining consensus among key stakeholders.<\/jats:p>\n <\/jats:sec>","DOI":"10.5863\/1551-6776-27.3.263","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:09:46Z","timestamp":1647886186000},"page":"263-269","source":"Crossref","is-referenced-by-count":2,"title":["Adherence to a Pediatric Continuous Infusion Propofol Policy for Sedation in Mechanically Ventilated Patients: Opportunities for Change and Improvement"],"prefix":"10.5863","volume":"27","author":[{"given":"Ashley M.","family":"Martin","sequence":"first","affiliation":[{"name":"Department of Pharmacy (AMM, AT, PDR), Children's Hospital Colorado, Anschutz Medical Campus, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tribuzi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (AMM, AT, PDR), Children's Hospital Colorado, Anschutz Medical Campus, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie L.","family":"Schieber","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (AMM, AT, PDR), Children's Hospital Colorado, Anschutz Medical Campus, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela D.","family":"Reiter","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (AMM, AT, PDR), Children's Hospital Colorado, Anschutz Medical Campus, Aurora, CO"},{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences (MLS, PDR), University of Colorado, Anschutz Medical Campus, Aurora, CO."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3883","reference":[{"issue":"7","key":"i2331-348X-27-3-263-b1","series-title":"CNS Drugs","first-page":"543","article-title":"Propofol: a review of its role in pediatric anesthesia and sedation","volume":"29","year":"2015","unstructured":"Chidambaran\n V,\n \n \n Costandi\n A,\n \n \n D'Mello\n A.\n \n \n Propofol: a review of its role in pediatric anesthesia and sedation.\n\t\t\t\t\tCNS Drugs.\n\t\t\t\t\t2015;\n\t\t\t\t\t29(\n\t\t\t\t\t7):\n\t\t\t\t\t543\u2013\n\t\t\t\t\t563."},{"issue":"8","key":"i2331-348X-27-3-263-b2","series-title":"Front Pediatr","first-page":"255","article-title":"Propofol infusion is a feasible bridge to extubation in general pediatric intensive care unit","volume":"28","year":"2020","unstructured":"Bhalala\n US,\n \n \n Patel\n A,\n \n \n Thangavelu\n M,\n \n \n .\n\t\t\t\t\tPropofol infusion is a feasible bridge to extubation in general pediatric intensive care unit.\n\t\t\t\t\tFront Pediatr.\n\t\t\t\t\t2020;\n\t\t\t\t\t28(\n\t\t\t\t\t8):\n\t\t\t\t\t255."},{"issue":"1","key":"i2331-348X-27-3-263-b3","series-title":"J Pediatr Pharmacol Ther","first-page":"17","article-title":"Propofol-related infusion syndrome in critically ill pediatric patients: coincidence, association, or causation?","volume":"11","year":"2006","unstructured":"Timpe\n EM,\n \n \n Eichner\n SF,\n \n \n Phelps\n SJ.\n \n \n Propofol-related infusion syndrome in critically ill pediatric patients: coincidence, association, or causation?\n \n J Pediatr Pharmacol Ther\n .\n\t\t\t\t\t2006;\n\t\t\t\t\t11(\n\t\t\t\t\t1):\n\t\t\t\t\t17\u2013\n\t\t\t\t\t42."},{"issue":"8","key":"i2331-348X-27-3-263-b4","series-title":"Intensive Care Med","first-page":"1125","article-title":"Consensus guidelines on sedation and analgesia in critically ill children","volume":"32","year":"2006","unstructured":"Playfor\n S,\n \n \n Jenkins\n I,\n \n \n Boyles\n C.\n \n \n Consensus guidelines on sedation and analgesia in critically ill children.\n\t\t\t\t\tIntensive Care Med.\n\t\t\t\t\t2006;\n\t\t\t\t\t32(\n\t\t\t\t\t8):\n\t\t\t\t\t1125\u2013\n\t\t\t\t\t1136."},{"issue":"4","key":"i2331-348X-27-3-263-b5","series-title":"Pediatrics","first-page":"1002","article-title":"The FDA warning against prolonged sedation with propofol in children remains warranted","volume":"112","year":"2003","unstructured":"Felmet\n K,\n \n \n Nguyen\n T,\n \n \n Clark\n RS,\n \n \n .\n\t\t\t\t\tThe FDA warning against prolonged sedation with propofol in children remains warranted.\n\t\t\t\t\tPediatrics.\n\t\t\t\t\t2003;\n\t\t\t\t\t112(\n\t\t\t\t\t4):\n\t\t\t\t\t1002\u2013\n\t\t\t\t\t1003."},{"issue":"6","key":"i2331-348X-27-3-263-b6","series-title":"J Pediatr Pharmacol Ther","first-page":"473","article-title":"Survey of pharmacists regarding the use of propofol infusions in the PICUs in North America","volume":"24","year":"2019","unstructured":"Kurek\n KJ,\n \n \n Harthan\n AA,\n \n \n Tripathi\n S.\n \n \n Survey of pharmacists regarding the use of propofol infusions in the PICUs in North America.\n\t\t\t\t\tJ Pediatr Pharmacol Ther.\n\t\t\t\t\t2019;\n\t\t\t\t\t24(\n\t\t\t\t\t6):\n\t\t\t\t\t473\u2013\n\t\t\t\t\t478."},{"issue":"4","key":"i2331-348X-27-3-263-b7","series-title":"Curr Opin Anaesthesiol","first-page":"404","article-title":"Propofol infusion syndrome in anaesthesia and intensive care medicine","volume":"19","year":"2006","unstructured":"Fudickar\n A,\n \n \n Bein\n B,\n \n \n Tonner\n PH.\n \n \n Propofol infusion syndrome in anaesthesia and intensive care medicine.\n\t\t\t\t\tCurr Opin Anaesthesiol.\n\t\t\t\t\t2006;\n\t\t\t\t\t19(\n\t\t\t\t\t4):\n\t\t\t\t\t404\u2013\n\t\t\t\t\t410."},{"issue":"7","key":"i2331-348X-27-3-263-b8","series-title":"Anaesthesia","first-page":"690","article-title":"Propofol infusion syndrome","volume":"62","year":"2007","unstructured":"Kam\n PC,\n \n \n Cardone\n D.\n \n \n Propofol infusion syndrome.\n\t\t\t\t\tAnaesthesia.\n\t\t\t\t\t2007;\n\t\t\t\t\t62(\n\t\t\t\t\t7):\n\t\t\t\t\t690\u2013\n\t\t\t\t\t701."},{"key":"i2331-348X-27-3-263-b9","series-title":"Circulation","first-page":"S526","article-title":"2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care","volume":"132","year":"2015","unstructured":"de Caen\n AR,\n \n \n Berg\n MD,\n \n \n Chameides\n L.\n \n \n 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.\n\t\t\t\t\tCirculation.\n\t\t\t\t\t2015;\n\t\t\t\t\t132:\n\t\t\t\t\tS526\u2013\n\t\t\t\t\tS542."},{"issue":"9","key":"i2331-348X-27-3-263-b10","series-title":"Ann Pharmacother","first-page":"1453","article-title":"Propofol infusion syndrome in critically ill patients","volume":"36","year":"2002","unstructured":"Kang\n TM.\n \n \n Propofol infusion syndrome in critically ill patients.\n\t\t\t\t\tAnn Pharmacother.\n\t\t\t\t\t2002;\n\t\t\t\t\t36(\n\t\t\t\t\t9):\n\t\t\t\t\t1453\u2013\n\t\t\t\t\t1456."},{"issue":"5","key":"i2331-348X-27-3-263-b11","series-title":"Crit Care","first-page":"R169","article-title":"Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study","volume":"13","year":"2009","unstructured":"Roberts\n RJ,\n \n \n Barletta\n JF,\n \n \n Fong\n JJ,\n \n \n .\n\t\t\t\t\tIncidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study.\n\t\t\t\t\tCrit Care.\n\t\t\t\t\t2009:\n\t\t\t\t\t13(\n\t\t\t\t\t5):\n\t\t\t\t\tR169."},{"issue":"4","key":"i2331-348X-27-3-263-b12","series-title":"Br J Anaesth","first-page":"448","article-title":"Propofol infusion syndrome: a structured literature review and analysis of published case reports","volume":"122","year":"2019","unstructured":"Hemphill\n S,\n \n \n McMenamin\n L,\n \n \n Bellamy\n MC,\n \n \n Hopkins\n PM.\n \n \n Propofol infusion syndrome: a structured literature review and analysis of published case reports.\n\t\t\t\t\tBr J Anaesth.\n\t\t\t\t\t2019;\n\t\t\t\t\t122(\n\t\t\t\t\t4):\n\t\t\t\t\t448\u2013\n\t\t\t\t\t459."},{"key":"i2331-348X-27-3-263-b13","article-title":"Medication Error Prevention \u201cToolbox\u201d","unstructured":"Institute for Safe Medication Practices.\n \n Medication Error Prevention \u201cToolbox\u201d.\n\t\t\t\t\tAccessed March 22, 2021. https:\/\/www.ismp.org\/resources\/medication-error-prevention-toolbox"},{"key":"i2331-348X-27-3-263-b14","article-title":"Sentinel event alert: preventing pediatric medication errors","unstructured":"Joint Commission.\n \n Sentinel event alert: preventing pediatric medication errors.\n\t\t\t\t\tAccessed March 22, 2021. www.jointcommission.org"},{"issue":"2","key":"i2331-348X-27-3-263-b15","series-title":"J Hosp Med","first-page":"90","article-title":"Standardized admission order set improves perceived quality of pediatric inpatient care","volume":"4","year":"2009","unstructured":"Bekmezian\n A,\n \n \n Chung\n PJ,\n \n \n Yazdani\n S.\n \n \n Standardized admission order set improves perceived quality of pediatric inpatient care.\n\t\t\t\t\tJ Hosp Med.\n\t\t\t\t\t2009;\n\t\t\t\t\t4(\n\t\t\t\t\t2):\n\t\t\t\t\t90\u2013\n\t\t\t\t\t96."},{"issue":"2","key":"i2331-348X-27-3-263-b16","series-title":"Pediatr Crit Care Med","first-page":"e66","article-title":"Is propofol a friend or a foe of the pediatric intensivist: description of propofol use in a PICU","volume":"15","year":"2014","unstructured":"Koriyama\n H,\n \n \n Duff\n JP,\n \n \n Guerra\n GG,\n \n \n .\n\t\t\t\t\tIs propofol a friend or a foe of the pediatric intensivist: description of propofol use in a PICU.\n\t\t\t\t\tPediatr Crit Care Med.\n\t\t\t\t\t2014;\n\t\t\t\t\t15(\n\t\t\t\t\t2):\n\t\t\t\t\te66\u2013\n\t\t\t\t\te71."},{"issue":"3","key":"i2331-348X-27-3-263-b17","series-title":"Br J Anaesth","first-page":"276","article-title":"Metabolic, biochemical and haemodynamic effects of infusion of propofol for long-term sedation of children undergoing intensive care","volume":"79","year":"1997","unstructured":"Martin\n PH,\n \n \n Murthy\n BVS,\n \n \n Petros\n J.\n \n \n Metabolic, biochemical and haemodynamic effects of infusion of propofol for long-term sedation of children undergoing intensive care.\n\t\t\t\t\tBr J Anaesth.\n\t\t\t\t\t1997;\n\t\t\t\t\t79(\n\t\t\t\t\t3):\n\t\t\t\t\t276\u2013\n\t\t\t\t\t279."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/27\/3\/article-p263.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/27\/3\/263\/3031372\/i2331-348x-27-3-263.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/27\/3\/article-p263.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/27\/3\/article-p263.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:36:57Z","timestamp":1747355817000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/27\/3\/article-p263.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":17,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-27.3.263","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"value":"2331-348X","type":"electronic"},{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}